- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and “the vanguard of 21st century healthcare” by the U.S. Department of Health and Human Services.
According to our latest study, the global Regenerative Medicine market size was valued at USD 34340 million in 2022 and is forecast to a readjusted size of USD 111830 million by 2029 with a CAGR of 18.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Regenerative Medicine key players include J & J (DePuy Synthes), Medtronic, Allergan(Acelity), Zimmer Biomet, etc. Global top four manufacturers hold a share about 10%.
North America is the largest market, with a share about 25%, followed by Europe, and Asia Pacific, both have a share over 40 percent.
In terms of product, Tissue Engineering is the largest segment, with a share over 40%. And in terms of application, the largest application is Dermatology, followed by Cardiovascular, CNS, Orthopedic, etc.
This report is a detailed and comprehensive analysis for global Regenerative Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Regenerative Medicine market size and forecasts, in consumption value ($ Million), 2018-2029
Global Regenerative Medicine market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Regenerative Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Regenerative Medicine market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Regenerative Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Regenerative Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include J & J (DePuy Synthes), Medtronic, Zimmer Biomet, Stryker and Allergan(Acelity), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Regenerative Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Cell Therapy
Tissue Engineering
Biomaterial
Other
Market segment by Application
Dermatology
Cardiovascular
CNS
Orthopedic
Others
Market segment by players, this report covers
J & J (DePuy Synthes)
Medtronic
Zimmer Biomet
Stryker
Allergan(Acelity)
MiMedx Group
Organogenesis
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
Nuvasive
Cook Biotech
Japan Tissue Engineering
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Regenerative Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Regenerative Medicine, with revenue, gross margin and global market share of Regenerative Medicine from 2018 to 2023.
Chapter 3, the Regenerative Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Regenerative Medicine market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Regenerative Medicine.
Chapter 13, to describe Regenerative Medicine research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Regenerative Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Regenerative Medicine by Type
1.3.1 Overview: Global Regenerative Medicine Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Regenerative Medicine Consumption Value Market Share by Type in 2022
1.3.3 Cell Therapy
1.3.4 Tissue Engineering
1.3.5 Biomaterial
1.3.6 Other
1.4 Global Regenerative Medicine Market by Application
1.4.1 Overview: Global Regenerative Medicine Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Dermatology
1.4.3 Cardiovascular
1.4.4 CNS
1.4.5 Orthopedic
1.4.6 Others
1.5 Global Regenerative Medicine Market Size & Forecast
1.6 Global Regenerative Medicine Market Size and Forecast by Region
1.6.1 Global Regenerative Medicine Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Regenerative Medicine Market Size by Region, (2018-2029)
1.6.3 North America Regenerative Medicine Market Size and Prospect (2018-2029)
1.6.4 Europe Regenerative Medicine Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Regenerative Medicine Market Size and Prospect (2018-2029)
1.6.6 South America Regenerative Medicine Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Regenerative Medicine Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 J & J (DePuy Synthes)
2.1.1 J & J (DePuy Synthes) Details
2.1.2 J & J (DePuy Synthes) Major Business
2.1.3 J & J (DePuy Synthes) Regenerative Medicine Product and Solutions
2.1.4 J & J (DePuy Synthes) Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 J & J (DePuy Synthes) Recent Developments and Future Plans
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Regenerative Medicine Product and Solutions
2.2.4 Medtronic Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Medtronic Recent Developments and Future Plans
2.3 Zimmer Biomet
2.3.1 Zimmer Biomet Details
2.3.2 Zimmer Biomet Major Business
2.3.3 Zimmer Biomet Regenerative Medicine Product and Solutions
2.3.4 Zimmer Biomet Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Zimmer Biomet Recent Developments and Future Plans
2.4 Stryker
2.4.1 Stryker Details
2.4.2 Stryker Major Business
2.4.3 Stryker Regenerative Medicine Product and Solutions
2.4.4 Stryker Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Stryker Recent Developments and Future Plans
2.5 Allergan(Acelity)
2.5.1 Allergan(Acelity) Details
2.5.2 Allergan(Acelity) Major Business
2.5.3 Allergan(Acelity) Regenerative Medicine Product and Solutions
2.5.4 Allergan(Acelity) Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Allergan(Acelity) Recent Developments and Future Plans
2.6 MiMedx Group
2.6.1 MiMedx Group Details
2.6.2 MiMedx Group Major Business
2.6.3 MiMedx Group Regenerative Medicine Product and Solutions
2.6.4 MiMedx Group Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 MiMedx Group Recent Developments and Future Plans
2.7 Organogenesis
2.7.1 Organogenesis Details
2.7.2 Organogenesis Major Business
2.7.3 Organogenesis Regenerative Medicine Product and Solutions
2.7.4 Organogenesis Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Organogenesis Recent Developments and Future Plans
2.8 Fujifilm Cellular Dynamics
2.8.1 Fujifilm Cellular Dynamics Details
2.8.2 Fujifilm Cellular Dynamics Major Business
2.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Product and Solutions
2.8.4 Fujifilm Cellular Dynamics Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Fujifilm Cellular Dynamics Recent Developments and Future Plans
2.9 Osiris Therapeutics
2.9.1 Osiris Therapeutics Details
2.9.2 Osiris Therapeutics Major Business
2.9.3 Osiris Therapeutics Regenerative Medicine Product and Solutions
2.9.4 Osiris Therapeutics Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Osiris Therapeutics Recent Developments and Future Plans
2.10 Vcanbio
2.10.1 Vcanbio Details
2.10.2 Vcanbio Major Business
2.10.3 Vcanbio Regenerative Medicine Product and Solutions
2.10.4 Vcanbio Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Vcanbio Recent Developments and Future Plans
2.11 CCBC
2.11.1 CCBC Details
2.11.2 CCBC Major Business
2.11.3 CCBC Regenerative Medicine Product and Solutions
2.11.4 CCBC Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 CCBC Recent Developments and Future Plans
2.12 Cytori
2.12.1 Cytori Details
2.12.2 Cytori Major Business
2.12.3 Cytori Regenerative Medicine Product and Solutions
2.12.4 Cytori Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Cytori Recent Developments and Future Plans
2.13 Celgene
2.13.1 Celgene Details
2.13.2 Celgene Major Business
2.13.3 Celgene Regenerative Medicine Product and Solutions
2.13.4 Celgene Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Celgene Recent Developments and Future Plans
2.14 Vericel Corporation
2.14.1 Vericel Corporation Details
2.14.2 Vericel Corporation Major Business
2.14.3 Vericel Corporation Regenerative Medicine Product and Solutions
2.14.4 Vericel Corporation Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Vericel Corporation Recent Developments and Future Plans
2.15 Guanhao Biotech
2.15.1 Guanhao Biotech Details
2.15.2 Guanhao Biotech Major Business
2.15.3 Guanhao Biotech Regenerative Medicine Product and Solutions
2.15.4 Guanhao Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Guanhao Biotech Recent Developments and Future Plans
2.16 Mesoblast
2.16.1 Mesoblast Details
2.16.2 Mesoblast Major Business
2.16.3 Mesoblast Regenerative Medicine Product and Solutions
2.16.4 Mesoblast Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Mesoblast Recent Developments and Future Plans
2.17 AMAG Pharmaceuticals (CBR)
2.17.1 AMAG Pharmaceuticals (CBR) Details
2.17.2 AMAG Pharmaceuticals (CBR) Major Business
2.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Product and Solutions
2.17.4 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 AMAG Pharmaceuticals (CBR) Recent Developments and Future Plans
2.18 ViaCord
2.18.1 ViaCord Details
2.18.2 ViaCord Major Business
2.18.3 ViaCord Regenerative Medicine Product and Solutions
2.18.4 ViaCord Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 ViaCord Recent Developments and Future Plans
2.19 CordLife
2.19.1 CordLife Details
2.19.2 CordLife Major Business
2.19.3 CordLife Regenerative Medicine Product and Solutions
2.19.4 CordLife Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 CordLife Recent Developments and Future Plans
2.20 Integra LifeSciences
2.20.1 Integra LifeSciences Details
2.20.2 Integra LifeSciences Major Business
2.20.3 Integra LifeSciences Regenerative Medicine Product and Solutions
2.20.4 Integra LifeSciences Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.20.5 Integra LifeSciences Recent Developments and Future Plans
2.21 Nuvasive
2.21.1 Nuvasive Details
2.21.2 Nuvasive Major Business
2.21.3 Nuvasive Regenerative Medicine Product and Solutions
2.21.4 Nuvasive Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.21.5 Nuvasive Recent Developments and Future Plans
2.22 Cook Biotech
2.22.1 Cook Biotech Details
2.22.2 Cook Biotech Major Business
2.22.3 Cook Biotech Regenerative Medicine Product and Solutions
2.22.4 Cook Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.22.5 Cook Biotech Recent Developments and Future Plans
2.23 Japan Tissue Engineering
2.23.1 Japan Tissue Engineering Details
2.23.2 Japan Tissue Engineering Major Business
2.23.3 Japan Tissue Engineering Regenerative Medicine Product and Solutions
2.23.4 Japan Tissue Engineering Regenerative Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.23.5 Japan Tissue Engineering Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Regenerative Medicine Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Regenerative Medicine by Company Revenue
3.2.2 Top 3 Regenerative Medicine Players Market Share in 2022
3.2.3 Top 6 Regenerative Medicine Players Market Share in 2022
3.3 Regenerative Medicine Market: Overall Company Footprint Analysis
3.3.1 Regenerative Medicine Market: Region Footprint
3.3.2 Regenerative Medicine Market: Company Product Type Footprint
3.3.3 Regenerative Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Regenerative Medicine Consumption Value and Market Share by Type (2018-2023)
4.2 Global Regenerative Medicine Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Regenerative Medicine Consumption Value Market Share by Application (2018-2023)
5.2 Global Regenerative Medicine Market Forecast by Application (2024-2029)
6 North America
6.1 North America Regenerative Medicine Consumption Value by Type (2018-2029)
6.2 North America Regenerative Medicine Consumption Value by Application (2018-2029)
6.3 North America Regenerative Medicine Market Size by Country
6.3.1 North America Regenerative Medicine Consumption Value by Country (2018-2029)
6.3.2 United States Regenerative Medicine Market Size and Forecast (2018-2029)
6.3.3 Canada Regenerative Medicine Market Size and Forecast (2018-2029)
6.3.4 Mexico Regenerative Medicine Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Regenerative Medicine Consumption Value by Type (2018-2029)
7.2 Europe Regenerative Medicine Consumption Value by Application (2018-2029)
7.3 Europe Regenerative Medicine Market Size by Country
7.3.1 Europe Regenerative Medicine Consumption Value by Country (2018-2029)
7.3.2 Germany Regenerative Medicine Market Size and Forecast (2018-2029)
7.3.3 France Regenerative Medicine Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Regenerative Medicine Market Size and Forecast (2018-2029)
7.3.5 Russia Regenerative Medicine Market Size and Forecast (2018-2029)
7.3.6 Italy Regenerative Medicine Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Regenerative Medicine Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Regenerative Medicine Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Regenerative Medicine Market Size by Region
8.3.1 Asia-Pacific Regenerative Medicine Consumption Value by Region (2018-2029)
8.3.2 China Regenerative Medicine Market Size and Forecast (2018-2029)
8.3.3 Japan Regenerative Medicine Market Size and Forecast (2018-2029)
8.3.4 South Korea Regenerative Medicine Market Size and Forecast (2018-2029)
8.3.5 India Regenerative Medicine Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Regenerative Medicine Market Size and Forecast (2018-2029)
8.3.7 Australia Regenerative Medicine Market Size and Forecast (2018-2029)
9 South America
9.1 South America Regenerative Medicine Consumption Value by Type (2018-2029)
9.2 South America Regenerative Medicine Consumption Value by Application (2018-2029)
9.3 South America Regenerative Medicine Market Size by Country
9.3.1 South America Regenerative Medicine Consumption Value by Country (2018-2029)
9.3.2 Brazil Regenerative Medicine Market Size and Forecast (2018-2029)
9.3.3 Argentina Regenerative Medicine Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Regenerative Medicine Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Regenerative Medicine Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Regenerative Medicine Market Size by Country
10.3.1 Middle East & Africa Regenerative Medicine Consumption Value by Country (2018-2029)
10.3.2 Turkey Regenerative Medicine Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Regenerative Medicine Market Size and Forecast (2018-2029)
10.3.4 UAE Regenerative Medicine Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Regenerative Medicine Market Drivers
11.2 Regenerative Medicine Market Restraints
11.3 Regenerative Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Regenerative Medicine Industry Chain
12.2 Regenerative Medicine Upstream Analysis
12.3 Regenerative Medicine Midstream Analysis
12.4 Regenerative Medicine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Regenerative Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Regenerative Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Regenerative Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Regenerative Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 5. J & J (DePuy Synthes) Company Information, Head Office, and Major Competitors
Table 6. J & J (DePuy Synthes) Major Business
Table 7. J & J (DePuy Synthes) Regenerative Medicine Product and Solutions
Table 8. J & J (DePuy Synthes) Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. J & J (DePuy Synthes) Recent Developments and Future Plans
Table 10. Medtronic Company Information, Head Office, and Major Competitors
Table 11. Medtronic Major Business
Table 12. Medtronic Regenerative Medicine Product and Solutions
Table 13. Medtronic Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Medtronic Recent Developments and Future Plans
Table 15. Zimmer Biomet Company Information, Head Office, and Major Competitors
Table 16. Zimmer Biomet Major Business
Table 17. Zimmer Biomet Regenerative Medicine Product and Solutions
Table 18. Zimmer Biomet Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Zimmer Biomet Recent Developments and Future Plans
Table 20. Stryker Company Information, Head Office, and Major Competitors
Table 21. Stryker Major Business
Table 22. Stryker Regenerative Medicine Product and Solutions
Table 23. Stryker Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Stryker Recent Developments and Future Plans
Table 25. Allergan(Acelity) Company Information, Head Office, and Major Competitors
Table 26. Allergan(Acelity) Major Business
Table 27. Allergan(Acelity) Regenerative Medicine Product and Solutions
Table 28. Allergan(Acelity) Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Allergan(Acelity) Recent Developments and Future Plans
Table 30. MiMedx Group Company Information, Head Office, and Major Competitors
Table 31. MiMedx Group Major Business
Table 32. MiMedx Group Regenerative Medicine Product and Solutions
Table 33. MiMedx Group Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. MiMedx Group Recent Developments and Future Plans
Table 35. Organogenesis Company Information, Head Office, and Major Competitors
Table 36. Organogenesis Major Business
Table 37. Organogenesis Regenerative Medicine Product and Solutions
Table 38. Organogenesis Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Organogenesis Recent Developments and Future Plans
Table 40. Fujifilm Cellular Dynamics Company Information, Head Office, and Major Competitors
Table 41. Fujifilm Cellular Dynamics Major Business
Table 42. Fujifilm Cellular Dynamics Regenerative Medicine Product and Solutions
Table 43. Fujifilm Cellular Dynamics Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Fujifilm Cellular Dynamics Recent Developments and Future Plans
Table 45. Osiris Therapeutics Company Information, Head Office, and Major Competitors
Table 46. Osiris Therapeutics Major Business
Table 47. Osiris Therapeutics Regenerative Medicine Product and Solutions
Table 48. Osiris Therapeutics Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Osiris Therapeutics Recent Developments and Future Plans
Table 50. Vcanbio Company Information, Head Office, and Major Competitors
Table 51. Vcanbio Major Business
Table 52. Vcanbio Regenerative Medicine Product and Solutions
Table 53. Vcanbio Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Vcanbio Recent Developments and Future Plans
Table 55. CCBC Company Information, Head Office, and Major Competitors
Table 56. CCBC Major Business
Table 57. CCBC Regenerative Medicine Product and Solutions
Table 58. CCBC Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. CCBC Recent Developments and Future Plans
Table 60. Cytori Company Information, Head Office, and Major Competitors
Table 61. Cytori Major Business
Table 62. Cytori Regenerative Medicine Product and Solutions
Table 63. Cytori Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Cytori Recent Developments and Future Plans
Table 65. Celgene Company Information, Head Office, and Major Competitors
Table 66. Celgene Major Business
Table 67. Celgene Regenerative Medicine Product and Solutions
Table 68. Celgene Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Celgene Recent Developments and Future Plans
Table 70. Vericel Corporation Company Information, Head Office, and Major Competitors
Table 71. Vericel Corporation Major Business
Table 72. Vericel Corporation Regenerative Medicine Product and Solutions
Table 73. Vericel Corporation Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Vericel Corporation Recent Developments and Future Plans
Table 75. Guanhao Biotech Company Information, Head Office, and Major Competitors
Table 76. Guanhao Biotech Major Business
Table 77. Guanhao Biotech Regenerative Medicine Product and Solutions
Table 78. Guanhao Biotech Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Guanhao Biotech Recent Developments and Future Plans
Table 80. Mesoblast Company Information, Head Office, and Major Competitors
Table 81. Mesoblast Major Business
Table 82. Mesoblast Regenerative Medicine Product and Solutions
Table 83. Mesoblast Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Mesoblast Recent Developments and Future Plans
Table 85. AMAG Pharmaceuticals (CBR) Company Information, Head Office, and Major Competitors
Table 86. AMAG Pharmaceuticals (CBR) Major Business
Table 87. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product and Solutions
Table 88. AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. AMAG Pharmaceuticals (CBR) Recent Developments and Future Plans
Table 90. ViaCord Company Information, Head Office, and Major Competitors
Table 91. ViaCord Major Business
Table 92. ViaCord Regenerative Medicine Product and Solutions
Table 93. ViaCord Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 94. ViaCord Recent Developments and Future Plans
Table 95. CordLife Company Information, Head Office, and Major Competitors
Table 96. CordLife Major Business
Table 97. CordLife Regenerative Medicine Product and Solutions
Table 98. CordLife Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 99. CordLife Recent Developments and Future Plans
Table 100. Integra LifeSciences Company Information, Head Office, and Major Competitors
Table 101. Integra LifeSciences Major Business
Table 102. Integra LifeSciences Regenerative Medicine Product and Solutions
Table 103. Integra LifeSciences Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 104. Integra LifeSciences Recent Developments and Future Plans
Table 105. Nuvasive Company Information, Head Office, and Major Competitors
Table 106. Nuvasive Major Business
Table 107. Nuvasive Regenerative Medicine Product and Solutions
Table 108. Nuvasive Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 109. Nuvasive Recent Developments and Future Plans
Table 110. Cook Biotech Company Information, Head Office, and Major Competitors
Table 111. Cook Biotech Major Business
Table 112. Cook Biotech Regenerative Medicine Product and Solutions
Table 113. Cook Biotech Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 114. Cook Biotech Recent Developments and Future Plans
Table 115. Japan Tissue Engineering Company Information, Head Office, and Major Competitors
Table 116. Japan Tissue Engineering Major Business
Table 117. Japan Tissue Engineering Regenerative Medicine Product and Solutions
Table 118. Japan Tissue Engineering Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Japan Tissue Engineering Recent Developments and Future Plans
Table 120. Global Regenerative Medicine Revenue (USD Million) by Players (2018-2023)
Table 121. Global Regenerative Medicine Revenue Share by Players (2018-2023)
Table 122. Breakdown of Regenerative Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 123. Market Position of Players in Regenerative Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 124. Head Office of Key Regenerative Medicine Players
Table 125. Regenerative Medicine Market: Company Product Type Footprint
Table 126. Regenerative Medicine Market: Company Product Application Footprint
Table 127. Regenerative Medicine New Market Entrants and Barriers to Market Entry
Table 128. Regenerative Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 129. Global Regenerative Medicine Consumption Value (USD Million) by Type (2018-2023)
Table 130. Global Regenerative Medicine Consumption Value Share by Type (2018-2023)
Table 131. Global Regenerative Medicine Consumption Value Forecast by Type (2024-2029)
Table 132. Global Regenerative Medicine Consumption Value by Application (2018-2023)
Table 133. Global Regenerative Medicine Consumption Value Forecast by Application (2024-2029)
Table 134. North America Regenerative Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 135. North America Regenerative Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 136. North America Regenerative Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 137. North America Regenerative Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 138. North America Regenerative Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 139. North America Regenerative Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 140. Europe Regenerative Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 141. Europe Regenerative Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 142. Europe Regenerative Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 143. Europe Regenerative Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 144. Europe Regenerative Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 145. Europe Regenerative Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 146. Asia-Pacific Regenerative Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 147. Asia-Pacific Regenerative Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 148. Asia-Pacific Regenerative Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 149. Asia-Pacific Regenerative Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 150. Asia-Pacific Regenerative Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 151. Asia-Pacific Regenerative Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 152. South America Regenerative Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 153. South America Regenerative Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 154. South America Regenerative Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 155. South America Regenerative Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 156. South America Regenerative Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 157. South America Regenerative Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 158. Middle East & Africa Regenerative Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 159. Middle East & Africa Regenerative Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 160. Middle East & Africa Regenerative Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 161. Middle East & Africa Regenerative Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 162. Middle East & Africa Regenerative Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 163. Middle East & Africa Regenerative Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 164. Regenerative Medicine Raw Material
Table 165. Key Suppliers of Regenerative Medicine Raw Materials
List of Figures
Figure 1. Regenerative Medicine Picture
Figure 2. Global Regenerative Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Regenerative Medicine Consumption Value Market Share by Type in 2022
Figure 4. Cell Therapy
Figure 5. Tissue Engineering
Figure 6. Biomaterial
Figure 7. Other
Figure 8. Global Regenerative Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Regenerative Medicine Consumption Value Market Share by Application in 2022
Figure 10. Dermatology Picture
Figure 11. Cardiovascular Picture
Figure 12. CNS Picture
Figure 13. Orthopedic Picture
Figure 14. Others Picture
Figure 15. Global Regenerative Medicine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 16. Global Regenerative Medicine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 17. Global Market Regenerative Medicine Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 18. Global Regenerative Medicine Consumption Value Market Share by Region (2018-2029)
Figure 19. Global Regenerative Medicine Consumption Value Market Share by Region in 2022
Figure 20. North America Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 21. Europe Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. Asia-Pacific Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. South America Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. Middle East and Africa Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 25. Global Regenerative Medicine Revenue Share by Players in 2022
Figure 26. Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 27. Global Top 3 Players Regenerative Medicine Market Share in 2022
Figure 28. Global Top 6 Players Regenerative Medicine Market Share in 2022
Figure 29. Global Regenerative Medicine Consumption Value Share by Type (2018-2023)
Figure 30. Global Regenerative Medicine Market Share Forecast by Type (2024-2029)
Figure 31. Global Regenerative Medicine Consumption Value Share by Application (2018-2023)
Figure 32. Global Regenerative Medicine Market Share Forecast by Application (2024-2029)
Figure 33. North America Regenerative Medicine Consumption Value Market Share by Type (2018-2029)
Figure 34. North America Regenerative Medicine Consumption Value Market Share by Application (2018-2029)
Figure 35. North America Regenerative Medicine Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 37. Canada Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 38. Mexico Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 39. Europe Regenerative Medicine Consumption Value Market Share by Type (2018-2029)
Figure 40. Europe Regenerative Medicine Consumption Value Market Share by Application (2018-2029)
Figure 41. Europe Regenerative Medicine Consumption Value Market Share by Country (2018-2029)
Figure 42. Germany Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 43. France Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 44. United Kingdom Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 45. Russia Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 46. Italy Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 47. Asia-Pacific Regenerative Medicine Consumption Value Market Share by Type (2018-2029)
Figure 48. Asia-Pacific Regenerative Medicine Consumption Value Market Share by Application (2018-2029)
Figure 49. Asia-Pacific Regenerative Medicine Consumption Value Market Share by Region (2018-2029)
Figure 50. China Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 51. Japan Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 52. South Korea Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 53. India Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 54. Southeast Asia Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 55. Australia Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 56. South America Regenerative Medicine Consumption Value Market Share by Type (2018-2029)
Figure 57. South America Regenerative Medicine Consumption Value Market Share by Application (2018-2029)
Figure 58. South America Regenerative Medicine Consumption Value Market Share by Country (2018-2029)
Figure 59. Brazil Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 60. Argentina Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 61. Middle East and Africa Regenerative Medicine Consumption Value Market Share by Type (2018-2029)
Figure 62. Middle East and Africa Regenerative Medicine Consumption Value Market Share by Application (2018-2029)
Figure 63. Middle East and Africa Regenerative Medicine Consumption Value Market Share by Country (2018-2029)
Figure 64. Turkey Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 65. Saudi Arabia Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 66. UAE Regenerative Medicine Consumption Value (2018-2029) & (USD Million)
Figure 67. Regenerative Medicine Market Drivers
Figure 68. Regenerative Medicine Market Restraints
Figure 69. Regenerative Medicine Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Manufacturing Cost Structure Analysis of Regenerative Medicine in 2022
Figure 72. Manufacturing Process Analysis of Regenerative Medicine
Figure 73. Regenerative Medicine Industrial Chain
Figure 74. Methodology
Figure 75. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
